PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape

This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice...

9 Elo 20182h 4min

The goal of the course is to provide both a basic and real-world application of immunotherapy for genitourinary oncology. The course is directed towards the urologist with an interest, but no prior ex...

1 Elo 20181h 55min

This course will offer a review of what faculty believe are the most important articles in the English-speaking literature on prostate cancer from May 2017 to April 2018. Focus will be placed on artic...

29 Heinä 20181h 59min

Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, and prostate cancers. Indications, outcomes, and toxicities will be discussed as wel...

25 Heinä 20181h 54min

We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether bi...

11 Heinä 20182h 1min

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

5 Heinä 201831min

Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active...

23 Kesä 20182h 12min

Dr. Nitti and Dr. Davis discus the use of focal therapy in the treatment of prostate cancer. @jdhdavis - This file has been updated

15 Kesä 201833min